SCHEMBL20076517

SCHEMBL20076517

CCCCCCCC(C)(CCCCCC)CC[C@H](CO)CC(=O)OCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 2/20 0.39
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
KDM4E B2RXH2 1/20 0.36
DUSP3 P51452 1/20 0.36
MAPK1 P28482 1/20 0.36
TLR4 O00206 1/20 0.35
PRKCA P17252 3/20 0.35
PRKCE Q02156 1/20 0.35
PRKCQ Q04759 1/20 0.35
PRKCD Q05655 1/20 0.35
HTT P42858 1/20 0.34
GAA P10253 1/20 0.33
ZDHHC7 Q9NXF8 1/20 0.33
NAAA Q02083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19861404 0.95 MEN1 (0.39) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL19861534 0.95 MEN1 (0.39) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL19861450 0.89 LMNA (0.39) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL20076506 0.89 LMNA (0.39) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL1101306 0.84 LMNA (0.57) MEN1KMT2AMAPTATMLMNA
SCHEMBL19861353 0.83 LMNA (0.36) LMNACYP4F2CYP4A11GAA
SCHEMBL15183610 0.81 ALDH1A1 (0.39) KMT2AL3MBTL1CYP4F2CYP4A11HTT
SCHEMBL15183604 0.81 ALDH1A1 (0.39) KMT2AL3MBTL1CYP4F2CYP4A11HTT
SCHEMBL15187368 0.80 ALDH1A1 (0.50) MEN1KMT2AMAPTATMLMNA
SCHEMBL20076321 0.78 GAA (0.35) L3MBTL1CYP4F2CYP4A11GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647747-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2020-05-12 US disclosed
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647747-B2 Cyclosporin derivatives and uses thereof FKBP5, FKBP1B, MALT1 MEN1 523/4885KMT2A 4492/4885MAPT 1415/4885
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 MEN1 786/4885KMT2A 4495/4885MAPT 1874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.